ImmuCell Corporation (NASDAQ: ICCC) is a Maine‐based biotechnology company specializing in immunological products for livestock health. Since its founding in the 1970s, the company has focused on developing solutions that enhance disease resistance and overall well‐being in dairy and beef cattle. ImmuCell’s portfolio is built on proprietary technologies designed to support passive immunity transfer in neonatal calves and to protect against common bacterial infections in adult cows.
The company’s flagship offering, First Defense, is a colostrum supplement formulated to reinforce calves’ immune systems shortly after birth. By supplying key antibodies and bioactive proteins, this product aims to reduce morbidity and mortality associated with scours and other early‐life infections. In addition, ImmuCell markets a range of mastitis prevention and therapeutic products that target intramammary infections, helping dairy producers maintain udder health and optimize milk quality.
ImmuCell distributes its products through a network of veterinary clinics, feed dealers and agricultural cooperatives across the United States, Canada and select international markets. The company partners with veterinary professionals to provide educational support, technical training and on‐farm implementation advice, ensuring its products are integrated into herd health protocols. By combining research‐driven formulations with practical guidance, ImmuCell positions itself as a trusted collaborator in the global livestock health arena.
Headquartered in Portland, Maine, ImmuCell operates state‐of‐the‐art research facilities dedicated to vaccine and immunology research. Under the leadership of CEO David Davies and a seasoned management team, the company continues to invest in product innovation and regulatory compliance. ImmuCell’s board comprises industry veterans in animal health, regulatory affairs and agricultural economics, reflecting a governance structure aimed at long‐term growth and scientific excellence.
AI Generated. May Contain Errors.
